Printer Friendly

First Loci technology-based PSA assays.

With PSA testing on the rise as prostate cancer awareness grows, labs can consolidate this testing on the Dimension Vista[R] 1500 Intelligent Lab System. Two new high-precision assays aid in the detection of prostate cancer: Total PSA (TPSA) and free PSA (FPSA), for use on the Vista system, offer high sensitivity, quick reaction times, low sample volumes, and simpler homogenous processing, with no washing or separation steps. The assays employ LOCI[R] technology, which uses an oxygen channeling mechanism that provides unlimited signal generation and requires fewer reaction steps, resulting in fast turnaround times.




COPYRIGHT 2012 NP Communications, LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Industry spotlight
Publication:Medical Laboratory Observer
Date:Apr 1, 2012
Previous Article:Prevention of perinatal group B streptococcal disease: highlights from revised CDC guidelines (2010).
Next Article:Selectra ProM chemistry system supports laboratory diagnostics.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters